Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation

Jonas Philipp Becker1, Johanna Weiss1, Dirk Theile1

  • 1Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Toxicology Letters
|November 27, 2013
PubMed

Insights

Platinum drugs like cisplatin can impact protein synthesis by affecting messenger RNA (mRNA). This study shows cisplatin, but not oxaliplatin or carboplatin, significantly inhibits mRNA translation, revealing mRNA as a functional target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Platinum-based chemotherapy agents, including cisplatin, oxaliplatin, and carboplatin, are known to target DNA.
  • Limited research exists on the interaction of these platinum drugs with messenger RNA (mRNA) and their differential effects on protein synthesis inhibition.

Purpose of the Study:

  • To investigate the effects of cisplatin, oxaliplatin, and carboplatin on mRNA translation in vitro.
  • To determine if mRNA is a functional target for platinum-based antineoplastic agents.

Main Methods:

  • An in vitro translation system was established using mRNA encoding green fluorescent protein (GFP).
  • GFP mRNA was exposed to varying concentrations (0-100 μM) of cisplatin, oxaliplatin, or carboplatin.
  • Drug-mRNA interactions were assessed by monitoring crossing-points in quantitative real-time polymerase chain reactions (qRT-PCR).
  • The impact on protein synthesis was evaluated by measuring GFP translation.

Main Results:

  • Cisplatin (100 μM) significantly increased qRT-PCR crossing-points and markedly reduced GFP mRNA translation.
  • Oxaliplatin exhibited a trend towards reduced GFP mRNA translation.
  • Carboplatin did not significantly affect GFP mRNA translation.

Conclusions:

  • This study provides the first evidence of differential effects of platinum cytostatics on mRNA translation.
  • Messenger RNA (mRNA) is demonstrated to be a functionally relevant target for at least cisplatin.
  • The findings suggest distinct mechanisms of action for platinum-based drugs beyond DNA interaction.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.4K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K